2018-01-11 12:04:01 |
Interview with Cynata Co-Founder Professor Slukvin |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8583cc078598ac1004ebf012c45b1602 |
Company Administration - Other
|
2018-01-11 19:08:07 |
Release of Securities from Voluntary Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/70eed88ddcd3eab659de2ead467ebf51 |
|
2018-01-22 09:33:29 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b9b890678bf0ca1a7f65d019c6ad21eb |
|
2018-01-22 12:17:01 |
Encouraging Early Data-Cynata Clinical Trial Proceeds |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fc46e2023c281ca1a0087988b86b78f4 |
|
2018-01-23 09:42:37 |
Lapse of Unlisted Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4fc2a2ccf7be205ed8bc0a33903e5479 |
|
2018-01-23 09:59:53 |
Cyanta & Celularity Inc Execute MOU |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1980982fe95bafc5207c2bb9ca8c1169 |
|
2018-01-24 09:38:31 |
Cynata Treats First Patient in Cohort B |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3423673aec940277f2d2e2d97173c11e |
|
2018-01-30 17:03:59 |
December 2017 Quarterly Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d2a8e7eaa147e7bb84c97caad6a43a5f |
Commitments Test Entity - Second Quarter Report
|
2018-02-05 09:22:17 |
Cynata Engineered MSC Study Review Reveals Promising Results |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e98c5a0c23c909750dab7d91e96367d0 |
|
2018-02-27 10:21:18 |
Excellent Data from Final Preliminary Evaluation Period |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b99ab2cd94c6430ac8658ecd4171b89c |
|
2018-02-27 17:47:42 |
Appendix 4D & Half-Year Financial Statements |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6e8c3a720fbe21b27cc32a7d225a1a60 |
Half Year Directors' Statement
Half Year Directors' Report
|
2018-02-28 13:33:27 |
Response to ASX Aware Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b6917dc456cd75b9017fd5fe954fad94 |
|
2018-02-28 17:53:50 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6186bb6721207fcb25d59d42c08bd183 |
|
2018-02-28 17:55:51 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e57ec559348a3f3ee91a1a8bad804a15 |
|
2018-03-12 09:48:46 |
Shaw and Partners Updates Cynata Research Coverage |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f42b81be555c3a562c9cbf0505e4c423 |
|
2018-03-13 09:39:37 |
Updated Top 20 Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/97a2d589e46f1996137876e6861a7c6e |
|
2018-03-13 17:11:10 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/edce90e0eca04aa303642436b350d80b |
|
2018-03-13 17:11:11 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d3675f088f60d98958d99f4d84e836e8 |
|
2018-03-28 09:42:40 |
FDA Grants Orphan Drug Designation to Cyanta for CYP-001 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/36d63e5bac40dcab0008efdb184c403c |
|
2018-03-28 15:44:43 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/15563d757ca7aa60dc970a26e90e26b0 |
|
2018-03-28 15:45:44 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6913a236599c73947d7027eb48c46f7e |
|
2018-04-04 16:43:42 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9223e885b70564e6601e4424b62210a6 |
|
2018-04-04 16:44:43 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/935e8e401e241d8937250310464c5119 |
|
2018-04-11 09:35:28 |
Further US Patent Granted for Cynata Cymerus Technology |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1c4a6998f9211868ce06a7fb133fa724 |
|
2018-04-12 12:28:25 |
Cyanta to Present at ARM Investor Day |
0 |
https://app.sharelinktechnologies.com/announcement/asx/609a4bc99160580e1ac0f33a1ed4e53f |
|
2018-04-20 09:38:36 |
CYP Completes Patent Application related to CAR-T Therapy |
1 |
https://app.sharelinktechnologies.com/announcement/asx/12e3d936799e2b0358df48a9a8b83734 |
|
2018-04-24 17:02:00 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d5cef59801362d68e6f29fd21331f823 |
|
2018-04-24 17:05:01 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/16eb11bff38223342a66171bb84089a7 |
|
2018-04-27 14:07:03 |
March 2018 Quarterly Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/46a9cc9b11fbcccb5cdcb48f56988128 |
Commitments Test Entity - Third Quarter Report
|
2018-05-07 10:30:21 |
Notice of Allowance from EPO for Patent Application |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e1809be2825cb9f839636d65d60ccc3f |
|
2018-05-07 17:52:44 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/500c14479bd4f4e0b7ac99f14b2fb612 |
Becoming a substantial holder
|
2018-05-15 17:23:22 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/db442ffc16ca11528139c6a8d94bc79c |
|
2018-05-15 17:24:23 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/815a11620136ed9c1d5bf3f3b356c2fc |
|
2018-05-22 15:02:58 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/48124de78b2c6b293810c2c9627c4d1f |
|
2018-05-22 15:03:59 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1b7ef0cb8c49675e7ed8b89c16344776 |
|
2018-05-24 09:10:08 |
Enrolment Completed in Cynata's Phase 1 Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5818429ea727ee4af6f79814b6241cf1 |
|
2018-05-28 10:26:24 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1d39cb93c2e3af1383a5d7848f928025 |
|
2018-05-30 09:45:08 |
$5.2m placement of shares to Fidelity International |
1 |
https://app.sharelinktechnologies.com/announcement/asx/88234146b3d5bdd2470336667e2d484f |
|
2018-05-31 09:26:24 |
Cynata's MSCs Effective in Model of Diabetic Wounds |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3a3fd948da7112e60d2c397514d25d40 |
|
2018-06-04 12:23:21 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/34258715e5ff882f02ac74e9b0397306 |
|
2018-06-04 12:24:22 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b9b947bc03e0815e64c7eded009fa344 |
|
2018-06-07 08:23:03 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/16610474044174870eb70fcb66c69f1b |
Change in substantial holding
|
2018-06-12 09:31:28 |
Positive 6-Month Data from Cohort 1 in Phase 1 Trial in GvHD |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1cfa3c16c79db0903806f1ebedeaf994 |
|
2018-06-18 09:41:39 |
Research Collaboration with UNSW for Coronary Artery Disease |
1 |
https://app.sharelinktechnologies.com/announcement/asx/77a3cb7792183645c4f8c5991c446fbd |
|
2018-06-21 09:33:31 |
Positive 28-day Clinical Trial Data in Cohort B |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1ec514690eaac401636cc9a990171d6c |
|
2018-06-26 09:08:04 |
Product Development Program Update & Investor Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1842261f6efb73794ac76b53781aa6c0 |
|
2018-07-02 09:35:28 |
Cynata Enters Development Partnership with RCSI |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b9e7f011807255a3d535307dbf92f618 |
|
2018-07-06 17:26:23 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e9e5b9dadca040a17ac4be68d0e67d4c |
|
2018-07-06 17:27:24 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e79d882a13c04f54e252ac9a700dba84 |
|
2018-07-11 17:40:39 |
June 2018 Quarterly Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c8481da9ca54d0fba66c281ddb617edd |
Commitments Test Entity - Fourth Quarter Report
|
2018-07-11 18:51:48 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2c87b516afef8c5eecc0927b75931a8b |
|
2018-07-11 18:52:49 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2ec601bd3cda09ccaae4408491776281 |
|
2018-07-16 17:49:48 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/be0cc96c2f55f2a38f58d46be3f9b286 |
|
2018-07-16 17:56:54 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6fc91ca817d0203ef8aea2774838b0f2 |
|
2018-07-31 09:35:28 |
Cymerus MSCs improve cardiac recovery in preclinical study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c6e9e0cc147f102d7de2cc0c57e5a1e9 |
|
2018-08-10 18:03:56 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b47134f686b2e46c1beb6428115eb618 |
Notice of General Meeting
|
2018-08-22 16:13:07 |
Appendix 4E & Financial Statements |
1 |
https://app.sharelinktechnologies.com/announcement/asx/79eb0eba7826dfbcd455137dd270434f |
Full Year Directors' Statement
Full Year Directors' Report
|
2018-08-22 16:14:08 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3ddbec9bade5d90004562d7c69250817 |
|
2018-08-24 18:09:07 |
Updated Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cd1e5fb0c4a075fdad9927ce6febd052 |
|
2018-08-30 09:25:21 |
Cynata GvHD Trial Meets all Safety & Efficacy Endpoints |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5d5ac4621f8bb410910541ac3eefcf8a |
|
2018-08-31 15:20:12 |
Cynata to Present at Rodman & Renshaw Investor Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a634a850cd7985fa943f19086f13764f |
|
2018-09-03 09:30:20 |
Cynata Advances to Official Meeting with Japanese PMDA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1a1d025b65dc583360808bbf80df0c90 |
|
2018-09-05 11:34:31 |
Director Loan Funded Shares-Voluntary Escrow Arrangement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/270b048d5062bcfe1d6f1982a3277168 |
|
2018-09-12 10:47:45 |
Results of Meeitng |
0 |
https://app.sharelinktechnologies.com/announcement/asx/72dbeb33c7a84b002a50f07e170d040c |
|
2018-09-19 09:44:41 |
Cynata MSCs Ameliorate CRS in Preclinical Study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8be246b70d6f1d13ddd2b63887a8656f |
|
2018-09-25 17:18:15 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/283807ee3f4a7b463284644e3ec36314 |
|
2018-09-25 17:19:18 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8e1cc31bbb4dc183f9f79e2b3d71dde7 |
|
2018-09-25 17:21:19 |
Appendix 3Y-Dr Paul Wotton |
0 |
https://app.sharelinktechnologies.com/announcement/asx/414048876162ec13b29a22e5f687cf70 |
Change of Director's Interest Notice
|
2018-09-25 17:22:20 |
Appendix 3Y-Dr Ross Macdonald |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6bedfc7698babba9e5b7b9f67a657eb2 |
Change of Director's Interest Notice
|
2018-09-25 17:24:21 |
Appendix 3Y-Dr Stewart Washer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fcf317ca55ab61bbbc8c26c7c262198f |
Change of Director's Interest Notice
|
2018-09-27 09:16:14 |
Notification of 2018 Annual General Meeting Date |
0 |
https://app.sharelinktechnologies.com/announcement/asx/11031f4d36ba3edc6b912dddd1491d77 |
Notice of Meeting - Other
|
2018-10-11 16:40:37 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d869c470cbd79e69f3d90777d5170409 |
Notice of Annual General Meeting
|
2018-10-11 16:45:39 |
Annual Report to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/024e54b07c71a1d85695f4c041505644 |
Full Year Directors' Statement
Full Year Directors' Report
|
2018-10-18 09:56:52 |
MSCs Demonstrate Anti-Cancer Effects in Pre-Clinical Studies |
1 |
https://app.sharelinktechnologies.com/announcement/asx/256ed6761a10e4f0088b14518c01868c |
|
2018-10-23 15:44:42 |
September 2018 Quarterly Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fff6b9eea66b8c8e9c49c4d84f81a04c |
Commitments Test Entity - First Quarter Report
|
2018-10-26 12:08:03 |
Appendix 3Y-Dr Paul Wotton |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0111cdccfb9dea6e4b187d18a1a1e30f |
Change of Director's Interest Notice
|
2018-11-01 12:24:19 |
Cyanta Outlook and Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5076f94e388ceb09817dcb706748629c |
|
2018-11-02 09:37:34 |
Cynata Clinical Trial Data Accepted for presentation at ASH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0c1d6181a50b93d64066e0075549c758 |
|
2018-11-07 09:30:28 |
CYP Receives Notice of Allowance from European Patent Office |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f56f239985979bd03aa86b649a58e7bc |
|
2018-11-15 10:07:03 |
Chairman's AGM Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b97a46cb24e90fb5690719d77085a7db |
Chairman's Address to Shareholders
|
2018-11-15 10:07:04 |
Annual General Meeting Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a399ac21c7e8a9a5e4183dc58edd4fea |
|
2018-11-15 12:57:54 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/daf9241af91810cd133db8d15e1b1d4d |
|
2018-11-15 14:25:23 |
Replacement-Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cab43732f65bf6b2045c31974304a72a |
|
2018-11-19 09:34:30 |
Cynata Receives $1.3m R&D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ae21a3e33b8ce9b9ee1b54faf0891bf6 |
|
2018-12-13 09:27:24 |
NHMRC Funding for Osteoarthritis Trial Using Cymerus MSCs |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6ea19011d4b3c933aa74b6bc21eba965 |
|
2018-12-18 09:23:14 |
Cynata Completes Clinical Study Report in GvHD |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3c01b74f2efe7b889c4835ca4ce91d61 |
|
2018-12-20 12:32:26 |
End of Year Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2496d28a7705ddd460360872c01b11ee |
|
2019-01-07 09:31:18 |
CYP Receives Notice of Acceptance from Aust Patent Office |
1 |
https://app.sharelinktechnologies.com/announcement/asx/01e206c64073bd83de884faa7de339f2 |
|
2019-01-29 11:58:54 |
Clinical trial results to be presented at major symposium |
0 |
https://app.sharelinktechnologies.com/announcement/asx/417479f547417a19620dbdf8b9ebe512 |
|
2019-01-29 17:43:41 |
December 2018 Quarterly Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/397a4b839e704cde5b405246350f8fd9 |
Commitments Test Entity - Second Quarter Report
|
2019-02-04 09:36:33 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/afe9509d5aef0636fe30c1f1ab0df2b6 |
|
2019-02-04 09:37:35 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b0921840064ca832ef48bec7bba8c9af |
|
2019-02-07 09:34:29 |
Study of CYP-001 Published in Leading Peer Review Journal |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a9da9ac840345429704854111203765b |
|
2019-02-11 11:50:48 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6354bd46189575ef5e78bb3f410c7f4c |
|
2019-02-11 11:51:49 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/028786ca6f2d6ecd2c2c4c55f889a4bd |
|
2019-02-11 11:57:55 |
Appendix 3Y-Dr John Chiplin |
0 |
https://app.sharelinktechnologies.com/announcement/asx/928ee13344df72f2c5c06839ad5eaacd |
Change of Director's Interest Notice
|
2019-02-18 11:49:47 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/80a318a494ecf1691f8d8f789444c069 |
|
2019-02-18 11:51:49 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d599746682370c05c3ab0afd759c16c7 |
|
2019-02-22 16:43:41 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/32c15d70966d57a1da0d167258bc574b |
|
2019-02-22 16:45:43 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cd6126d65491ff749645ef45e2757c95 |
|
2019-02-25 09:00:58 |
Further Cynata Asthma Study Published |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e2ab5891d9d9fa37b2986fd43bc0a89f |
|
2019-02-27 16:56:49 |
Appendix 4D & Half-Year Financial Statements |
1 |
https://app.sharelinktechnologies.com/announcement/asx/82ae63e650d5c3266f4fedcd7639139c |
Half Year Directors' Statement
Half Year Directors' Report
|
2019-03-04 09:15:10 |
Positive Pre-Clinical Coronary Artery Disease Data for CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/574649f63befb9d1f576b1579262593f |
|
2019-03-11 09:35:30 |
Joint Study of Cynata MSCs receives VMRAF Funding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9c0e28c0059a2acabe5eb4b7b1b9ca23 |
|
2019-03-12 09:37:33 |
Cynata Receives Favourable Advice on Planned CLI Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f9e1de5ecae4f9a9d51a2cee0519c65e |
|
2019-03-13 16:45:40 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3342605321237417fdb6162e188f5efa |
|
2019-03-13 16:46:42 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/04f7900043b678834e0933058c305469 |
|
2019-03-19 09:30:28 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6cbdc9eaed90003d1192e01071521529 |
|
2019-03-20 12:46:30 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a0214246ef1d7a57494b735bcfa6c4e7 |
|
2019-03-21 09:51:06 |
Cynata Extends FUJIFILM Licence Option in GvHD |
1 |
https://app.sharelinktechnologies.com/announcement/asx/39ff6ce6d8252f0309ad55832bcc9389 |
|
2019-03-21 09:51:08 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/18a2a014629cdfb5f0b0fa48ba956fbe |
|
2019-03-21 12:02:59 |
Extension of FUJIFILM Licence Option in GvHD |
0 |
https://app.sharelinktechnologies.com/announcement/asx/049da6e88e7eb1c2348b0b1a45b206b0 |
|
2019-04-04 09:33:31 |
European Patent Isued to Cynata Therapeutics |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b48135af92b0e316988f430e9c19661c |
|
2019-04-26 16:39:34 |
March 2019 Quarterly Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a5ff169b6297208324e05450151633f0 |
Commitments Test Entity - Third Quarter Report
|
2019-05-06 09:14:02 |
CYP Progresses Start-Up Activities for Clinical Trial in CLI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7d17ccb8cd088c222d29f873a51c2eb7 |
|
2019-05-07 13:09:07 |
Appendix 3B - Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c2cabcbf466f4770a99619cfd1a346f8 |
|
2019-05-07 13:11:08 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7237eabd11f68ffd931a654440e68c40 |
|
2019-05-07 13:14:12 |
Appendix 3Y-Dr John Chiplin |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3e52de96bc181932b9f71c32324fdf32 |
Change of Director's Interest Notice
|
2019-05-20 09:03:55 |
Cynata Strengthens Board & Executive Management Team |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f5ac2e0a5cefcec91d164f7db70d4263 |
Director Appointment/Resignation
|
2019-05-20 09:11:08 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/706cf0b2c5c8885a8baf38c573d0d995 |
|
2019-05-20 09:14:09 |
Appendix 3Y-Dr Geoff Brooke |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b8833c4db91b8e3e63039f285ab20d36 |
Initial Director's Interest Notice
|
2019-05-20 09:15:10 |
Appendix 3Z-Dr John Chiplin |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0bece003d7308fd9a808ac498192a93c |
Final Director's Interest Notice
|
2019-05-30 10:12:10 |
Cynata's Cymerus Technology Featured in ISCT Presentations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5da3123386290223a2c79ca9f0beeed9 |
Company Administration - Other
|
2019-07-04 09:44:39 |
June 2019 Quarterly Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2ed194c7830047de045ddbe794f9f455 |
Commitments Test Entity - Fourth Quarter Report
|
2019-07-17 09:18:14 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7961e4ea81b5005ce850cf05c940d6b6 |
|
2019-07-19 09:50:18 |
Cynata confirms receipt of indicative non-binding proposal |
1 |
https://app.sharelinktechnologies.com/announcement/asx/de9ea2834cfb07e51f50ebd9f6b9fbb0 |
Indicative Non-Binding Proposal
|
2019-07-19 09:50:44 |
Response to ASX Price and Volume Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2595fee7e1ead3f3249da5125b24a5b0 |
|
2019-07-24 16:19:17 |
Response to ASX Aware Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/39fa440cdc08c821a9db94cea3cbeeeb |
|
2019-08-02 17:15:11 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/33ffad26c4dc475bcea0720b93f9bf69 |
|
2019-08-02 17:16:13 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c62ffd6c304ee65286075eefa5356fcf |
|
2019-08-15 09:38:31 |
Update on Discussions with Sumitomo and Fujifilm |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2549f266d2df2e0ef3d2ec02118256fb |
|
2019-08-15 17:47:43 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/79fcefb67f76be1abf97c1b79854e073 |
|
2019-08-15 17:48:46 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/69350a335cf413b7c5152a96249f78df |
|
2019-08-23 17:10:05 |
Appendix 4E & Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/26f861f6efca49a15ebd19361090f15f |
Full Year Directors' Statement
Full Year Directors' Report
|
2019-08-23 17:12:07 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a9315463cb8cb6603358c6760f5e1a6d |
|
2019-08-27 16:04:01 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4b7bb690458ea05ad4b9a9356e4631b4 |
|
2019-08-27 16:09:04 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7847319627ab31a2dfdbac82d3347bd4 |
|
2019-09-03 16:05:45 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0077aea00ec21f73ccf8a5e125d5ada7 |
|
2019-09-03 16:07:04 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f597cbe23bc9da69842a0299c5991db |
|
2019-09-04 08:27:40 |
Cynata transplant rejection study accepted for publication |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d42dfe50077268af3092cd77863a1a2b |
|
2019-09-09 18:16:04 |
Expiry of Voluntary Escrow Arrangement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c9743ec45562a6dc2db0aa10697df62a |
|
2019-09-13 18:40:35 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/af6554462a382d7850604ae2ecb714b7 |
|
2019-09-17 18:49:41 |
Fujifilm Exercises License Option in GvHD |
1 |
https://app.sharelinktechnologies.com/announcement/asx/60837f1fdea92751fbc31f1f8032d7bf |
|
2019-09-18 12:14:12 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8e11acd762f38f32047c7c568cfe0c9f |
|
2019-09-18 12:15:13 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/37970dd22b02bc1263acd74b8ba00665 |
|
2019-09-26 09:35:31 |
Cynata Receives US$3 million Fujifilm License Fee |
1 |
https://app.sharelinktechnologies.com/announcement/asx/92bda2dcd968aff9c3c573fb9ad249c8 |
|
2019-09-27 16:30:29 |
Notification of 2019 Annual General Meeting Date |
0 |
https://app.sharelinktechnologies.com/announcement/asx/079bb45b5a2313b6c5e69df2d9d870f3 |
Notice of Meeting - Other
|
2019-10-03 08:36:33 |
CYP Advances Towards Osteoarthritis Phase 2 Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1736f28ddaecc175d1e8467f3f9899ec |
|
2019-10-14 19:56:42 |
Receipt of notice under section 249N of the Corporations Act |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a5eedff0fa890b89b43f23dc70fc9c8b |
Notice of Meeting - Other
|
2019-10-17 09:27:18 |
Cynata & Sumitomo Withdraw from Acquisition Discussions |
1 |
https://app.sharelinktechnologies.com/announcement/asx/63b9b497446c6483dfd3476cd92642e1 |
|
2019-10-24 09:18:12 |
September 2019 Quarterly Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bee5d04897e93271464873a8b9485706 |
Commitments Test Entity - First Quarter Report
|
2019-10-24 17:06:03 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8beb5bbb9d4f42a46697818565614a64 |
Notice of Annual General Meeting
|
2019-10-24 17:09:06 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ce2f2df0e320781074f5925468b506b0 |
Full Year Directors' Statement
Full Year Directors' Report
|
2019-10-25 09:28:23 |
Notice of Allowance from CIPO for Patent Application |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1ee42a1f55d709d79f445878d0e0b6a1 |
|
2019-10-28 09:41:31 |
Cynata Awarded Grant for Coronary Artery Disease Study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/13f16556bfdd30c7ddd14231ba42bf3c |
|
2019-10-30 08:58:56 |
Cynata Corporate Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/377fc8bbbc5a432b94a40a26d0720da0 |
|
2019-11-11 19:46:42 |
Appendix 3B-Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e775110d7ad4d0ccde6c90f42562bf5f |
|
2019-11-11 19:48:44 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/299c9f678635f95c9831655f73bee14a |
|
2019-11-11 19:50:48 |
Appendix 3Y-Dr Paul Wotton |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a47cfffc167cf312ac9b682f769b3804 |
Change of Director's Interest Notice
|
2019-11-11 19:51:49 |
Appendix 3Y-Dr Ross Macdonald |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e71be248b89f7e4fb050a81d934a3289 |
Change of Director's Interest Notice
|
2019-11-11 19:52:50 |
Appendix 3Y-Mr Peter Webse |
0 |
https://app.sharelinktechnologies.com/announcement/asx/34ad477071ec62d318b4f29aa93f89e7 |
Change of Director's Interest Notice
|
2019-11-18 09:26:24 |
Notification of Expiry of Unlisted Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b78d26dec961f796b48b392f0b3d4f85 |
|
2019-11-18 09:32:27 |
Appendix 3Y-Dr Paul Wotton |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a515437db70d095fbabfed758edd8a43 |
Change of Director's Interest Notice
|
2019-11-25 09:01:51 |
CYP Files Application to Commence Phase 2 CLI Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/81bc0397621d340fe90b651538e10a90 |
|
2019-11-27 09:01:58 |
Chairman's 2019 AGM Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f7b9b0a6cfdb76777271605c68c92c7 |
Chairman's Address to Shareholders
|
2019-11-27 09:03:00 |
Cynata Annual General Meeting Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2ff5df0d2c044b369d96b2456ece164c |
|
2019-11-27 13:16:13 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8ea18f3a4766685cac9415a1d8e6adb8 |
|
2019-12-05 09:23:16 |
Cymerus MSCs Effective in Preclinical Model of Sepsis |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2406598f53e1342b4a27f5b83a4eb060 |
|
2019-12-09 13:20:15 |
Corporate Presentation in Relation to Sepsis |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ebaf49dd8745bdb8ff0c1710b985b9b9 |
|
2019-12-16 19:25:18 |
Appendix 3Y-Dr Paul Wotton |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3ea5c4db5785ed8da4057df5cedaa87f |
Change of Director's Interest Notice
|
2020-01-07 09:23:21 |
Cynata Receives $1.892m R&D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/014719a19f7c89a87ae861c8544385e3 |
|
2020-01-14 09:21:18 |
Cynata Receives UK Regulatory Approval for CLI Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/90f419fe7e15a883fd6bf4bcb13835a7 |
|
2020-01-30 09:28:26 |
December 2019 Quarterly Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/16feab8ee6efb68b561d5a7bdeec536e |
Commitments Test Entity - Second Quarter Report
|
2020-01-31 12:15:13 |
Cynata Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ac75b5f5c27f90b5923c43cd23615991 |
|
2020-02-06 11:10:08 |
Notice of Allowance from Israel Patent Office |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1c2ef04a9f2e83d508f8a21312114cd2 |
|
2020-02-20 15:43:40 |
Appendix 4D & Half-Year Financial Statements |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a19c71fee921dde157a72c6ee8506c83 |
Half Year Directors' Statement
Half Year Directors' Report
|
2020-03-03 09:40:36 |
Canadian Patent Issued for CYP Unique Stem Cell Technology |
0 |
https://app.sharelinktechnologies.com/announcement/asx/630fb7b6be5f656df91457e144ef6170 |
|
2020-03-10 09:51:48 |
Cynata Receives Japan Patent Notice of Allowance |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ae8aaa5f8b68b702ad5293d7d9b502b2 |
|
2020-03-11 09:35:29 |
Market Update & Additional A$618k R&D Tax Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d76d6ad7d705f205baf514c69e38e90a |
|
2020-04-01 18:08:58 |
Cynata provides guidance on planned clinical trials |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6f3a39f8d92cd96e213df00cd84b463b |
|
2020-04-17 09:59:55 |
Cynata MSCs beneficial in preclinical ARDS study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e4fd510bd75f84bc9ab2490bd781f8a1 |
|
2020-04-20 10:19:43 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/669ad60ce90bb2d43681589e7ff315b0 |
|
2020-04-22 11:31:14 |
Proposed Issue of Securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e960b0bc2d8d901a3793bd1fb601f8b1 |
|
2020-04-22 11:32:06 |
Cynata announces $5.55m capital raising |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ede22a6fd773538d6548ca9ac7c225fe |
|
2020-04-24 08:31:28 |
Quarterly Activity Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/32a02a54c7602d16e2ee376d845c685b |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2020-04-24 08:55:48 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/25bad0236a56a48f62290eda5170c79c |
Appendix 2A (Application for Quotation of Securities
|
2020-04-24 09:03:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f3f85e7bfebbff80e11f9912e0ac3a0d |
|
2020-04-30 12:15:05 |
Share Purchase Plan Booklet |
1 |
https://app.sharelinktechnologies.com/announcement/asx/10e28c8d1198773b14a7df2df2fe19fc |
|
2020-05-01 11:30:28 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3f93c218b48a757b134954ca236098f7 |
Appendix 2A (Application for Quotation of Securities
|
2020-05-01 11:31:29 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/23a57c45753abaca6f4f7d4713fa933c |
|
2020-05-08 09:17:12 |
Ethics Approval to Commence Clinical Trial in COVID-19 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/35dc5c5cf40be3addc51a91dad905695 |
|
2020-05-27 09:08:02 |
Cynata Successfully Completes Share Purchase Plan |
1 |
https://app.sharelinktechnologies.com/announcement/asx/82f26d521f6095bcb08945dbaee4bce7 |
|
2020-06-02 09:37:22 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/455caee4dee355e937aa00bfcac27aba |
Appendix 2A (Application for Quotation of Securities
|
2020-06-10 09:27:24 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/416e3f885c48897ffdc310f1d1cbeb28 |
|
2020-06-10 16:59:51 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/92890cf8bde17fa8cfc49fbf5337ba6d |
Appendix 2A (Application for Quotation of Securities
|
2020-06-16 09:47:25 |
Block Trade Proceeds to Reduce Director Loans |
1 |
https://app.sharelinktechnologies.com/announcement/asx/96cd61193852232b819d9f2377d517de |
Security holder details - Other
|
2020-06-16 09:55:52 |
Dr Darryl Maher joins Cynata Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/64796303a385d85471d119058aa2da08 |
Director Appointment/Resignation
|
2020-06-16 10:36:34 |
Appendix 3Y-Stewart Washer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c5de32b8d622486b1756ca4245e30caa |
Change of Director's Interest Notice
|
2020-06-16 10:38:36 |
Appendix 3Y-Ross Macdonald |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a2c9454feb993e249588deae5d323d0f |
Change of Director's Interest Notice
|
2020-06-16 10:40:38 |
Appendix 3X-Darryl Maher |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a84b08ddbd75ac7603ac124e39b8da8f |
Initial Director's Interest Notice
|
2020-06-18 09:25:53 |
Ethics Approval & Expedited Pathway for Phase 3 OA Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c50c4ddc405bec7e765cd7f6bea8f72b |
|
2020-06-24 12:37:35 |
Appendix 3Y-Dr Geoff Brooke |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4c887b5682bc1583e6be8c8afa4fe48a |
Change of Director's Interest Notice
|
2020-07-01 08:30:22 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e240211261668b8d984cfab6cbfccd3f |
Final Director's Interest Notice
|
2020-07-01 08:31:24 |
Securities Dealing Policy |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f20446155357ab5ee859a8722f62b232 |
|
2020-07-20 16:17:15 |
Notification of Expiry of Unlisted Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d069e4794ca5ab302e65df2d7b83f8a6 |
|
2020-07-28 09:14:05 |
Quarterly Activity Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e29a6fae67ef9106e14257870f2c3fd8 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2020-07-30 09:48:43 |
Cynata Announces Positive Results from GvHD Trial Follow-up |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5354957700fca0bd2096f692c3831a7b |
|
2020-08-05 08:23:03 |
Notification of Expiry of Unlisted Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bdcea0bfc87dcf9a4af5b844024e9ee0 |
|
2020-08-07 09:01:59 |
Notice of Allowance from Korean Patent Office |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0db18472457627c1545179298283947e |
|
2020-08-14 09:22:17 |
Cynata Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eec321086d9cba139e5454fca7a5f89b |
|
2020-08-18 11:18:12 |
Cynata Appoints Dr Geoff Brooke as Chairman |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c5273022b02ef8d914c2cf1fca639b9b |
Director Appointment/Resignation
|
2020-08-19 17:02:34 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2de1cf5629b87345c23fca8e3228cb51 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2020-08-24 09:47:42 |
Patient Enrolment Opens in COVID-19 Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/083c174817364b858e42b1e37f342163 |
|
2020-08-25 18:45:33 |
Appendix 4E & Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/81ae60de83423badd2ae81ab33b181c0 |
Full Year Directors' Statement
Full Year Directors' Report
|
2020-08-25 18:46:36 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3e6f8cce4be86cd63fc5e7556636edf9 |
|
2020-09-07 09:42:39 |
Cymerus MSCs Effective in Preclinical Lung Disease Study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a3352d030c6dcd35fd8adc0e0c937a07 |
|
2020-09-14 18:44:41 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4bad53e91b27f83168f6b78a3fc944b0 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2020-09-15 08:18:51 |
Cynata Clinical Trial Results Published in Nature Medicine |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4e1357f2d69a606516f5510d3590214c |
Company Administration - Other
|
2020-09-24 09:20:18 |
Potential Utility of Cymerus MSCs in Heart Attack Model |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6cd82f26ebd1d4e2829b5e8198509fbb |
|
2020-10-06 16:36:33 |
Date of AGM & Closing Date for Director Nominations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/12b52c188913c5928622dcbf7c54667e |
Notice of Meeting - Other
|
2020-10-23 19:24:22 |
Letter to Shareholders, Notice of AGM & Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/650edf830d5187f9b5aa6a4bf06ed30b |
Notice of Annual General Meeting
|
2020-10-23 19:25:16 |
Annual Report to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ee63e4a6aabb37e9267df21c3b0fd222 |
Full Year Directors' Statement
Full Year Directors' Report
|
2020-10-29 13:17:14 |
AusBiotech Conference Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3c9c0397de6b187639d2add6b84f44af |
|
2020-10-30 10:01:59 |
Quarterly Activity Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e2b4bc6a4f6e64b111ac49520cfeceb4 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2020-11-11 09:39:32 |
Phase 3 Osteoarthritis Clinical Trial Commences |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b3ae7c072bfd77f6215342ba73014367 |
|
2020-11-18 10:21:19 |
Cynata Technology Featured on Front Cover of Nature Medicine |
0 |
https://app.sharelinktechnologies.com/announcement/asx/25747464462502ef6e30596f87cabda5 |
Company Administration - Other
|
2020-11-24 10:38:31 |
AGM Presentations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b71a919c80d44461d9db5100109e6291 |
Chairman's Address to Shareholders
|
2020-11-24 13:23:22 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5479e9b2c7006a111eaed05bc92aa77f |
|
2020-11-24 13:29:25 |
Replacement Constitution |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dfd2a73c016ab525ad2033bfa200d48b |
|
2020-11-30 19:04:01 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c5b33735354a20a6027b73adcccf7407 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2020-11-30 19:09:03 |
Appendix 3Ys x 5 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3a299290ce78399f33e17c89057db12a |
Change of Director's Interest Notice
|
2020-12-09 09:29:26 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/15572ff2765dd22f71d67adf7f8d3341 |
|
2020-12-11 09:16:05 |
CYP Closes $15m Institutional Placement to Expand Pipeline |
1 |
https://app.sharelinktechnologies.com/announcement/asx/02e97f5deb8c2630f212d4c5187fc6a0 |
|
2020-12-11 09:18:42 |
Proposed issue of Securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bc49db91245e02c9b49af18238bf60c4 |
|
2020-12-11 09:20:48 |
Investor Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0ff1e48e4e7d9091dd7c25aa18dac7cf |
|
2020-12-11 09:22:53 |
Notice Under Section 708AA of the Corporations Act |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5e29b2a2e619090b40aa0f4f7e6be7b5 |
|
2020-12-15 09:32:30 |
Letter to Optionholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1aaae89fd32f5a90a1f8efddca2898e1 |
|
2020-12-18 17:06:04 |
Cynata provides update on Placement and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b8fc742eec71d0a4df759dcafd137d66 |
Appendix 2A (Application for Quotation of Securities
|
2020-12-21 10:27:24 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4fb0ab0c352283661a32b2b2b4722d60 |
|
2020-12-21 14:33:30 |
Cynata Entitlement Offer Opens |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dfc5db3e7ac715fa152b83c26ad9d65b |
|
2020-12-21 14:46:42 |
Offer Booklet and Entitlement & Acceptance Form |
1 |
https://app.sharelinktechnologies.com/announcement/asx/148460848cec0f95d4287dd3458d4afc |
|
2020-12-21 14:47:44 |
Letter to Ineligible Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bdd963e3635f622cbf3c22c85ec1ca14 |
|
2020-12-23 13:01:48 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5a6ecdf36c86f81464e67021152a1e0f |
Appendix 2A (Application for Quotation of Securities
|
2020-12-24 09:42:39 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/51e640fbaec964efbffe8909510d1c92 |
|
2020-12-29 17:21:18 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e38933afaa158a08994a6597bac9d3bf |
Becoming a substantial holder
|
2020-12-30 09:14:11 |
2020 Review and Outlook |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4b71277e16aa5891d685974e28bcd75f |
Company Administration - Other
|
2020-12-30 15:56:53 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9ef68bf92aabbf941c2a59f1f99eac79 |
Appendix 2A (Application for Quotation of Securities
|
2020-12-31 09:40:38 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b36e26f332ff992e51b31157d298555e |
|
2021-01-11 09:18:15 |
Entitlement Offer Closing Date Reminder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a3606230dd7183019a440c81f37a6f1c |
|
2021-01-18 09:42:38 |
Completion of Entitlement Offer and Shortfall Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7cc62bddf9b2325d34cb1a4a1247ea34 |
|
2021-01-20 11:16:13 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/793a1e4c5e13cccadb2a6f8abaf07f11 |
Appendix 2A (Application for Quotation of Securities
|
2021-01-20 11:41:38 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/698c62ab0ab7b38f8c6032d3ae2941f0 |
|
2021-01-29 09:29:20 |
Quarterly Activity Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c71ae8ec4ad2c08f54d5661d92b9cef1 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2021-02-22 09:15:13 |
Cynata Receives $1.39m R&D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/687b8af95bf5b6d609762bc5bf85e6a9 |
|
2021-02-25 17:55:45 |
Appendix 4D & Half-Year Financial Statements |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7f85d37d542702cac8877e98f14456ea |
Half Year Directors' Statement
Half Year Directors' Report
|
2021-03-01 09:15:04 |
Cynata Advances Planned Clinical Trial in DFU with TekCyte |
0 |
https://app.sharelinktechnologies.com/announcement/asx/46832c2603ca0498418e8a8ac9192a28 |
|
2021-03-02 09:21:18 |
New Study to Investigate the High Potency of Cymerus MSCs |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5d30c2cfa662240d0e2b2957808318a3 |
|
2021-03-12 09:14:12 |
Cynata Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/93fe867cdef08e1dd46d1ee076b1b697 |
|
2021-03-29 09:43:38 |
Cynata Expands trial in COVID-19 & Respiratory Failure |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a98f902beaf2066d302a58a1da64f11a |
|
2021-04-28 09:15:13 |
Quarterly Activity Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fb72b9b1b597cb75bcd25cf7b194894b |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2021-05-24 12:10:08 |
First Patient Enrolled in Cynata MEND Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ba4fe0c686255540a5c923a09149f83a |
|
2021-05-28 17:38:36 |
Release of Securities from Voluntary Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d8c69329e345ef8ed027e241f44e264a |
|
2021-06-03 11:09:04 |
Cynata signs Licence Agreement with TekCyte |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d6c6a6dd280b62c2493d7d327980ea1b |
|
2021-06-11 14:41:39 |
Cynata to Present at MST Access Investor Conference 15 June |
0 |
https://app.sharelinktechnologies.com/announcement/asx/94cf5a6b428ccdc8b87fcc9a1f309019 |
|
2021-06-28 09:20:08 |
Progress Toward Clinical Trial in Diabetic Foot Ulcers |
1 |
https://app.sharelinktechnologies.com/announcement/asx/527be1c44952e80162a71aa69689d953 |
|
2021-06-30 09:49:46 |
Ethics Approval for Cynata's Clinical Trial in DFU |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e9b3c7e69c900e1804a25b5ad63d57ab |
|
2021-07-05 17:35:34 |
Change of Registered Office |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ecab0972bd6b37673bd87e591e2cfa9d |
Details of Registered office address
|
2021-07-26 11:19:12 |
Cynata Appoints Dr Jolanta Airey Chief Medical Officer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/66c554d9be4d24ca880881a02942862d |
Company Administration - Other
|
2021-07-28 09:07:05 |
Quarterly Activity Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0cebae115d2bced3da044eb4e2fd9711 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2021-08-26 13:24:22 |
Cynata Receives Notice of Allowance from US Patent Office |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bdfae986bc0dded0698bf62ff186cfe4 |
|
2021-08-30 12:55:47 |
Appendix 4E & Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/246cb5590bf717384e9028b79d0e2c7a |
Full Year Directors' Statement
Full Year Directors' Report
|
2021-08-30 12:56:54 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bb08ffd23ff9495e56ec6cb0f25ceaa4 |
|
2021-08-31 09:00:56 |
Further Canadian Patent for Cynata |
1 |
https://app.sharelinktechnologies.com/announcement/asx/29a07db76ce3a5c3367ba5557440aa4e |
|
2021-09-15 12:38:36 |
Further Patents for Cynata Unique Cymerus Technology |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d2b9a52845bf4bb74e49bfddaec81a3e |
|
2021-09-21 16:48:46 |
Date of AGM and Closing Date for Director Nominations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ec57348f59bce3591e0e93a074911e0b |
Notice of Meeting - Other
|
2021-09-28 09:29:27 |
CYP Preclinical Heart Attack Study Published in Cytotherapy |
0 |
https://app.sharelinktechnologies.com/announcement/asx/96f7389492212d235e7ede7bd70be4e5 |
|
2021-09-30 14:02:00 |
Cynata Enters into a New Strategic Partnership with Fujifilm |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dc34565b095927263d2d4128fe5b0564 |
|
2021-10-08 09:23:14 |
DSMB Recommends Continuation of Cynata's MEND Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/63f7324f4ca3e699e88e930b5239d656 |
|
2021-10-12 17:13:11 |
Notification regarding unquoted securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b8500bcd71e5612f554134fad64e765a |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2021-10-14 17:07:55 |
Letter to Shareholders & Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e66f818bcbde0e9367d79deb21bb74fc |
Notice of Annual General Meeting
|
2021-10-14 17:17:02 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/70b2d695fa7f907ace38de67e352161d |
Full Year Directors' Statement
Full Year Directors' Report
|
2021-10-18 09:33:27 |
Cynata Receives US$5m Fujifilm Fee |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8324ce4f7b9897db2cb89a76f0b0b990 |
|
2021-10-28 12:42:40 |
Quarterly Activity Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a1d8b2a51a0982701fe4bc4a8f4449c6 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2021-11-16 09:48:44 |
AGM Presentations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3879920e148bbe91c749372e271e2022 |
Chairman's Address to Shareholders
|
2021-11-16 13:55:51 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a3827ca11be8ba7a069d5df545791e54 |
|
2021-11-18 09:20:17 |
Site Initiation Visit Completed for CYP DFU Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ba0696d9b8b252d3f3adc77c110efa6d |
|
2021-12-01 12:05:01 |
Appendix 3Y - Dr Geoffrey Brooke |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2953d66bf28b427c49ecbf846645c343 |
Change of Director's Interest Notice
|
2021-12-02 14:34:31 |
Appendix 3Y- Dr Stewart Washer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e32386641124ee1a6d2a07e7c96384b4 |
Change of Director's Interest Notice
|
2021-12-20 14:26:32 |
Change of Registry Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8304947609015a9645179ddee76077d0 |
Details of Share Registry address
|
2021-12-22 08:43:36 |
Cynata Commences DFU Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/53235c01d77fc4421ec1394d6bd964ad |
|
2021-12-29 09:32:26 |
FUJIFILM Cellular Dynamics Executes Manufacturing Agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8405dffe85820f7c6b7d22b21cb2c7ab |
|
2022-01-19 09:24:23 |
Cynata Receives $832,677 R&D Tax Incentive Refund |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5bd14107ee69c48f7743b21fcc22b2ef |
|
2022-01-27 09:25:22 |
Cynata Receives Decision to Grant a Patent in Japan |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bf3ed57cc7982632482d68311973383c |
|
2022-01-28 15:15:14 |
Quarterly Activity Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/414dffb9092ea85f587b12260ae98047 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2022-02-25 14:59:54 |
Appendix 4D & Half-Year Financial Statements |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1187d09ff3b93fcf4361fb7ac670c26b |
Half Year Directors' Statement
Half Year Directors' Report
|
2022-02-28 09:30:24 |
Notice of Allowance for Cynata Chinese Patent |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fdad03f66c54eb9e4d04b7689fe31745 |
|
2022-03-08 09:07:05 |
Updated Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b64092fea1404b5ef746a3d1cf1073a1 |
|
2022-04-21 09:23:22 |
Cynata Advances Clinical Trial in Diabetic Foot Ulcers |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8acdec84d68e4b7572a5ef7d300d2852 |
|
2022-04-29 09:17:06 |
Quarterly Activity Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/794383d63dd40fa64dd7d9addfdcd6da |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2022-05-16 17:28:27 |
Notification of cessation of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dc6591515286031d7a77cdcec95e3eba |
Appendix 3H (Notification of cessation of securities)
|
2022-05-26 09:42:39 |
FDA Clears Cynata IND for Phase 2 Trial in GvHD |
1 |
https://app.sharelinktechnologies.com/announcement/asx/22e43c44b51affdfed16a59e6a7666a5 |
|
2022-05-30 09:16:14 |
Cynata Adds New Site for MEND Clinical Trial |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8165966b435723fee99e5fed2abb03a9 |
|
2022-06-14 09:12:09 |
Further data supports potency of Cynata MSCs |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2dc697ed9902b1e4e9278bf80449c019 |
|
2022-07-14 08:55:53 |
Notice of Allowance for Cynata US Patent |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4a281d9aa09e2b7d37ff6e7bd32e75ed |
|
2022-07-27 12:19:16 |
Quarterly Activity Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/57da4e62e7cc0c7eefc30395df7a9f59 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2022-08-12 09:16:13 |
Pipeline Update Following Strategic Portfolio Review |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1ea5b5a557c9ba4d1b2e4dfb7994ac00 |
|
2022-08-24 14:07:01 |
Appendix 4E & Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3d83f996edd77c55c91925ed5c0530da |
Full Year Directors' Statement
Full Year Directors' Report
|
2022-08-24 14:07:03 |
Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c700e99803640eab716df4c810f7b76 |
|
2022-08-24 14:08:05 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0d0e1c8e18a510bfec6faaf0afdf014d |
|
2022-08-29 09:04:59 |
Preclinical study in coronary artery disease published |
0 |
https://app.sharelinktechnologies.com/announcement/asx/44c1d53e7f1434a69d60563de1c4c50f |
Company Administration - Other
|
2022-08-30 09:10:01 |
Appointment of Ms Janine Rolfe to the Cynata Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1dae845de6a29852bc4b8e3fe943f69c |
Director Appointment/Resignation
|
2022-09-01 09:13:12 |
Appendix 3X - Janine Rolfe |
0 |
https://app.sharelinktechnologies.com/announcement/asx/06e9918ee88a4036d640db6a9972666a |
Initial Director's Interest Notice
|
2022-09-26 09:07:03 |
Grant Award to Fund Study of Cynata MSCs in Heart Disease |
1 |
https://app.sharelinktechnologies.com/announcement/asx/60c64e1511ca36a2e38118b322264ee0 |
|
2022-09-27 08:51:48 |
Date of AGM and Closing Date for Director Nominations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/12227ee67382158900230568bb3d7cc2 |
Notice of Meeting - Other
Company Administration - Other
|
2022-10-12 09:26:22 |
Successful Completion of Planned DSMB Review of DFU Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/db9f497e451097a152c309f0a56a79b6 |
|
2022-10-17 09:28:25 |
Notice of Allowance for Australia & Canada Cymerus Patents |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ae6a7ba804d00a6b4a59d586db50255f |
|
2022-10-21 16:46:42 |
Letter to Shareholders, Notice of AGM & Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/567a6cf9026c6a0fc96c073c6d10c0b6 |
Notice of Annual General Meeting
|
2022-10-21 16:51:44 |
Annual Report to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bb4f94aa27ecc7a0517c258f6e0f9d2d |
Full Year Directors' Statement
Full Year Directors' Report
|
2022-10-31 16:31:29 |
Quarterly Activity Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/68ed4d6eaaf2ee9e387b075e63645eb2 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2022-11-02 09:10:09 |
New Kidney Transplantation Clinical Trial for Cynata & LUMC |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0b783d157b452fde5812178824fb4404 |
Company Administration - Other
|
2022-11-07 16:52:50 |
Notification of cessation of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9c825b28784b101442a8cb2ca352ef08 |
Appendix 3H (Notification of cessation of securities)
|
2022-11-11 09:15:13 |
Notice of Allowance for Cynata US Patent |
1 |
https://app.sharelinktechnologies.com/announcement/asx/17872cd62e09492dd19214b34bc07601 |
|
2022-11-16 09:03:01 |
Conference Data Demonstrating Consistency of Cynata MSCs |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f0b6286075d7caca5b02c79aff047ea3 |
|
2022-11-22 08:52:47 |
AGM Presentations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/947310f49cdf59cb0d57ef8cdb71a651 |
Chairman's Address to Shareholders
|
2022-11-22 12:57:47 |
Results of AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8744baea5d346f6ca53fd446e6dc1a9a |
|
2022-11-23 11:20:17 |
Notification regarding unquoted securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2dfac46188481b8ca0bf24458997590e |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2022-11-23 11:23:19 |
Appendix 3Y - Janine Rolfe |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2d779b21bc9f539497d65dc2c1d152f2 |
Change of Director's Interest Notice
|
2022-12-05 08:56:55 |
Cynata Receives $1.65m R&D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/366f34d09568e70919e96a2b4fdfe388 |
|
2023-01-05 17:29:28 |
Notification of cessation of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/46360a9de7bf043eb8e055b45b09425f |
Appendix 3H (Notification of cessation of securities)
|
2023-01-09 12:41:38 |
Notice of Acceptance for Cynata Australian Patent |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fc5eec8d7209bdf61ffeb5ca9d47db54 |
|
2023-01-30 09:06:04 |
Cynata Receives IRB Approval for aGvHD Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8c8f7fa5472be638c5cd55b5ad5af41a |
|
2023-01-31 13:27:25 |
Quarterly Activity Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a3d867b9c2e5755ca0a2ec08bc6f3993 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2023-02-06 17:44:44 |
Notification of cessation of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6bb84e49ee445784cc4e80c70c13811e |
Appendix 3H (Notification of cessation of securities)
|
2023-02-28 15:05:03 |
Appendix 4D & Half-Year Financial Statements |
1 |
https://app.sharelinktechnologies.com/announcement/asx/46bdf78c085ebc2759039ca75e40c6c0 |
Half Year Directors' Statement
Half Year Directors' Report
|
2023-03-16 13:25:23 |
Cynata Adds New Sites for DFU Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d240d45f2e2f3ccb174b1a6d4cf7c023 |
|
2023-04-03 17:46:45 |
Notification of cessation of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/009c15e114be2083dec7b5cb6e705394 |
Appendix 3H (Notification of cessation of securities)
|
2023-04-04 09:20:19 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/105e08a416c44bf08c0b951ecca7d03f |
|
2023-04-06 09:24:30 |
Cynata completes $5.0m Placement and launches SPP |
1 |
https://app.sharelinktechnologies.com/announcement/asx/057ec8a68b2ccab9e013c80130f9ce10 |
|
2023-04-06 09:24:33 |
Proposed issue of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7889489d0b56d8ce6cc57780a66fd92a |
|
2023-04-06 09:26:34 |
Capital Raising Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6c29a708f46ae8423f6d37555544d028 |
|
2023-04-12 09:37:26 |
Ethics Committee Approval for Proposed aGvHD Phase 2 Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/24c085ef5c42cdcae992982b8c525c95 |
|
2023-04-17 09:21:21 |
Application for quotation of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d028368f2154c5439ae739d33644fc29 |
Appendix 2A (Application for Quotation of Securities
|
2023-04-17 09:23:22 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/70f44b5021072f2b933713b71c8980fe |
|
2023-04-19 15:42:38 |
Share Purchase Plan Booklet & Option Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8dd1e81ed7756eeedfe92a2ae25252f4 |
|
2023-04-19 16:27:21 |
Target Market Determination |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1a521140d22de3542e426f09291e7fbe |
|
2023-04-24 09:36:35 |
Application for quotation of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0b877d8568048aa4bf3c7fbb7fbfcd6e |
Appendix 2A (Application for Quotation of Securities
|
2023-04-24 09:39:38 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9f2f6f4279b7132f7a4305f8806d5ce7 |
|
2023-04-24 10:52:46 |
Letter to Shareholders, Notice of Meeting & Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aed4d844631af1f808e032158ac9e25a |
Notice of Extraordinary General Meeting
|
2023-04-24 12:14:13 |
Proposed issue of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5aadfcd33f21426631ac813f6e5946f3 |
|
2023-04-28 12:46:42 |
Quarterly Activity Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a16e012dcc1a10f5e38ce96880c656d8 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2023-05-10 12:54:51 |
Cynata Completes Oversubscribed Share Purchase Plan |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7abd7d07aa42f1976fce4a0413df0b01 |
|
2023-05-11 09:57:56 |
Application for quotation of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1d90d72e8faa8af92b45d4488b3cb0f1 |
Appendix 2A (Application for Quotation of Securities
|
2023-05-22 10:22:19 |
Two-Year Results of Phase 1 SR-aGvHD Trial Presented at ISCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/857b4b2e19603d9f1b7943cc9e8e43b0 |
|
2023-05-25 11:04:02 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/88fb4b16a592d6224e67a18c87a46049 |
|
2023-05-31 12:53:52 |
Application for quotation of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ef17fa2c9f8bdbb48be6ee7f901b3646 |
Appendix 2A (Application for Quotation of Securities
|
2023-05-31 12:55:54 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/49c363e80c755b345910dfd3c8ba8e17 |
|
2023-06-01 09:48:45 |
Application for quotation of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/32c31eda437091da77867991764d53b9 |
Appendix 2A (Application for Quotation of Securities
|
2023-06-01 09:51:50 |
Top 20 Listed Optionholders & Distribution Schedule |
0 |
https://app.sharelinktechnologies.com/announcement/asx/72c2009b7a8c69045a7151851a0383cd |
|
2023-06-01 16:23:21 |
Appendix 3Ys x 6 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/13bff06a250902b60ac458fbe42eb029 |
Change of Director's Interest Notice
|
2023-06-15 08:23:30 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/28e44cc49961bd3dd2dd5702d753d191 |
Change in substantial holding
|
2023-06-30 09:13:09 |
Cynata announces CEO succession and Board changes |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9d4d7b5caf837627bce237a11409eb88 |
Director Appointment/Resignation
|
2023-06-30 09:44:41 |
Proposed issue of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6af13d07dbbcd3100ad5ced706d3482d |
|
2023-06-30 13:10:08 |
Notification regarding unquoted securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aa0a2b2fde5d9bfe5c3a5ef2b256b784 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-07-03 13:24:22 |
Final Director's Interest Notice - Ross Macdonald |
0 |
https://app.sharelinktechnologies.com/announcement/asx/541ba8b4ce60fa705b04a3269517713e |
Final Director's Interest Notice
|
2023-07-03 13:27:24 |
Final Director's Interest Notice - Stewart Washer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0e67b45df4ced1acebf86af6084379bb |
Final Director's Interest Notice
|
2023-07-03 13:27:25 |
Initial Director's Interest Notice - Kilian Kelly |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a8d41cd09162a020e8770a6a10d46a7c |
Initial Director's Interest Notice
|
2023-07-03 13:28:27 |
Initial Director's Interest Notice - David Atkins |
0 |
https://app.sharelinktechnologies.com/announcement/asx/416114c868c1ad8ce42779cd15443726 |
Initial Director's Interest Notice
|
2023-07-24 09:39:36 |
Strategic Review of Cynata Clinical Development Portfolio |
1 |
https://app.sharelinktechnologies.com/announcement/asx/475b88de005e765869756b6621f68d06 |
|
2023-07-25 17:04:02 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/de56b57a4ebb73dc85ff860874a6fbc0 |
Ceasing to be a substantial holder
|
2023-07-26 09:03:01 |
Quarterly Activity Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4ad43be84ac478af2a17f8fcd4bdaab4 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2023-07-27 08:21:49 |
Investor Webinar Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bb5c5d782f0390edf6bc5f1121f30424 |
|
2023-08-10 09:03:59 |
Phase 2 Trial of CYP-001 in aGvHD Open for Recruitment |
1 |
https://app.sharelinktechnologies.com/announcement/asx/aa743adb19f858399d3cdd1fed8d77f8 |
|
2023-08-21 09:13:11 |
Approval of Clinical Trial of CYP-001 in Kidney Transplant |
1 |
https://app.sharelinktechnologies.com/announcement/asx/439bdf30a6bc8e250162f3b6607ec9dd |
|
2023-08-28 17:57:48 |
Appendix 4E & Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7e4bf0db053e8b61d4188d75fa90a7bc |
Full Year Directors' Statement
Full Year Directors' Report
|
2023-08-28 17:57:52 |
Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/57e949cf92c6337b9e76aa7952aa1d7e |
|
2023-08-28 17:57:53 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7c691025f108a9eb37398dc9d9a12b07 |
|
2023-09-18 09:41:39 |
Date of AGM and Closing Date for Director Nominations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d07f6f10a0c85b2451799ae73fd74de9 |
Notice of Meeting - Other
Company Administration - Other
|
2023-09-18 16:33:28 |
Investor Webinar Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/471cad4e651b77792648df8a084778d7 |
Security holder details - Other
|
2023-10-09 08:57:55 |
Dr David Atkins not to stand for re-election at AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/61ceb3149263e72ba60a28823eee38bf |
Notice of Meeting - Other
Director Appointment/Resignation
|
2023-10-12 14:41:38 |
Letter to Shareholders, Notice of AGM & Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/123fd66a1a711bbde02b7b60bbb518f8 |
Notice of Annual General Meeting
|
2023-10-12 14:43:40 |
Annual Report to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5ef5af11d63ce733870b6204bd2ccf27 |
Full Year Directors' Statement
Full Year Directors' Report
|
2023-10-26 14:18:15 |
Quarterly Activity Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/28560deb7aada2e5ccc9e188df308e8b |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2023-11-02 09:30:28 |
First USA site initiated in aGvHD trial |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1e327222c12adcc4d36bdce0f81c9579 |
|
2023-11-06 09:14:09 |
Phase 3 SCUlpTOR Osteoarthritis Clinical Trial Progress |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5b9bea1527929d8f9c6c226b77092f1a |
|
2023-11-13 08:32:14 |
AGM Presentations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/80fecf5d039ee9a063fa47d71abffe60 |
Chairman's Address to Shareholders
|
2023-11-13 12:40:37 |
Results of AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b09d7ded1195be2216e1a944d7b04a26 |
|
2023-11-13 14:45:38 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e4e65f9d1165ae71496d966d210bf415 |
Final Director's Interest Notice
|
2023-11-14 08:55:51 |
Cynata Receives $2.315m R&D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/27d9f355d6dba648f94d589ffb8e88bb |
|
2023-11-14 16:29:29 |
Notification of cessation of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/24dc8968c3052ed8cd2a1bf1ea7d4b01 |
Appendix 3H (Notification of cessation of securities)
|
2023-11-20 16:31:27 |
Notification regarding unquoted securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ee732a6d8f452a9ba6af50458235a6b9 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-11-20 16:41:39 |
Appendix 3Ys x 5 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/64c08bcc7f923c1bf288662bae92148a |
Change of Director's Interest Notice
|
2023-11-23 09:13:12 |
Appendix 3Y - Dr Kilian Kelly |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d5e61d0d44de5a82332f30662a3c3706 |
Change of Director's Interest Notice
|
2023-12-07 09:39:35 |
Phase 2 Trial of CYP-001 in aGvHD Approved in Turkey |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e0fa6ac7f7a6ddf39eef8d4299365c12 |
|
2023-12-13 09:46:44 |
Recruitment Completed in Phase 3 OA Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e9300998deb38d9174c60a78dac400ef |
|
2023-12-28 08:52:50 |
Initial Results in First 16 DFU Patients Expected in Q1 2024 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/17a871e91d879e2ecb8d0ea8f1c982a0 |
|
2024-01-16 16:29:25 |
Notification regarding unquoted securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/232beee8851639e6c540eebaad04451b |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-01-30 08:56:52 |
Quarterly Activity Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/628be9ab77613e4659f64550e7aad19d |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2024-02-23 15:22:19 |
Appendix 4D & Half-Year Financial Statements |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a68242134b4b6320f1f28040365bbd0a |
Half Year Directors' Statement
Half Year Directors' Report
|
2024-02-26 09:01:00 |
Encouraging Initial Data from CYP-006TK DFU Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/77f3e4f38a0bc5be2ee008ac78761d55 |
|
2024-02-29 09:19:16 |
Cynata Appoints New Chief Business Officer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/33977c8a594230cf2d79776cd0543c18 |
Company Administration - Other
|
2024-03-05 08:54:52 |
First Patient Treated in Phase 2 GvHD Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/66dac3363c5d23c07292b7172a80ffae |
|
2024-03-18 08:52:49 |
Cynata Presenting at Advanced Therapies Congress |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9986d881b3f47a97a3232dd69b7003ae |
|
2024-03-20 08:55:53 |
EU Approval for Phase 2 CYP-001 Trial in GvHD |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4b0a4c6bb60d3f86d0534a9cae05497d |
|
2024-04-08 08:58:55 |
DFU Clinical Trial Enrolment Complete |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6dc0e56d33545b944d4e744451b1a211 |
|
2024-04-17 13:36:29 |
Notification regarding unquoted securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bc5c1dc4b3e61665d14c8ee19da4cb86 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-04-30 08:54:45 |
Quarterly Activity Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d7230cf905fcfdb679955c96eb6213d4 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2024-05-07 11:35:34 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4733c918288e65f301f4e16e1057c6fd |
|
2024-05-17 08:25:05 |
Notification of cessation of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/acad9d47d452f79257a6aaee61997bb9 |
Appendix 3H (Notification of cessation of securities)
|
2024-05-17 08:26:09 |
Appendix 3Y-Dr Geoffrey Brooke |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d416825b4f09b04e6eb6251bf6585689 |
Change of Director's Interest Notice
|
2024-05-22 19:10:04 |
Further GvHD Clinical Data Published in Nature Medicine |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bb54288ace67e2beffef1e6e26046fc1 |
|
2024-05-29 08:38:37 |
CYP Presents at Major International Cell Therapy Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/67c02bbea4e72f6da03f9ca6bbedfad2 |
|
2024-06-27 09:02:00 |
Sharewise Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ed462ff6e4a76b1061b30c95bbdc8907 |
|
2024-07-01 09:49:48 |
Cynata to Acquire IP from Tekcyte |
1 |
https://app.sharelinktechnologies.com/announcement/asx/431d74d215f0080aeef8a7b5dc2631c8 |
|
2024-07-01 09:51:50 |
Proposed issue of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cdc6bd4be914d4b4cb3608caa483e6e5 |
|
2024-07-12 09:20:16 |
Cynata Presents at Bioshares Summit |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d73d49e941b2daef6229fa515f9b9f34 |
|
2024-07-19 15:08:07 |
Application for quotation of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2711d7ba737520a57c3b42c49b36b81b |
Appendix 2A (Application for Quotation of Securities
|
2024-07-30 08:40:40 |
Quarterly Activity Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/401f1c47268f1700945f7380c0c01124 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2024-07-31 12:05:04 |
Application for quotation of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4deed028ea51a66f6ad751fab62eaf8c |
Appendix 2A (Application for Quotation of Securities
|
2024-07-31 12:11:10 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/502021249c31fbae598c1ecd6dd8911b |
|
2024-08-08 09:49:48 |
Study of Cymerus MSCs in Pulmonary Fibrosis Published |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1ef56ef2ba708c6c27b2b6a40725aac5 |
|
2024-08-09 09:12:09 |
Cynata to Present at ISCT Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0796209aaafaa1d5d7b30c97b1012252 |
Company Administration - Other
|
2024-08-19 08:22:13 |
Notification of cessation of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/269470280b52766e35b1484e56dafbba |
Appendix 3H (Notification of cessation of securities)
|
2024-08-19 08:27:26 |
Appendix 3Y - Dr Kilian Kelly |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cdce98a19f4070cbdcb273f565efff3d |
Change of Director's Interest Notice
|
2024-08-19 17:14:14 |
Proposed issue of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/31b9accb03440e5a26911e5045938486 |
|
2024-08-29 18:07:02 |
Appendix 4E & Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/212d9f8ac7ef8c19758dca95bc5facdd |
Full Year Directors' Statement
Full Year Directors' Report
|
2024-08-29 18:07:04 |
Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6f7406b3abf5db1db66ec407d6a12d35 |
|
2024-08-29 18:07:05 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/65a690ff3f988f30048d52a050485f54 |
|
2024-08-30 14:34:31 |
Investor Webinar |
0 |
https://app.sharelinktechnologies.com/announcement/asx/43d5934b7722853788eabd22745feb45 |
|
2024-09-02 14:25:24 |
Application for quotation of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ee04e923f5b33a4e32137fe831c6e76f |
Appendix 2A (Application for Quotation of Securities
|
2024-09-02 14:29:28 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9250dd2f401a2d115f8b26e36ca6554d |
|
2024-09-05 08:30:28 |
Investor Webinar Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aabd0d12181425d50865647b04b904b3 |
|
2024-09-13 16:17:08 |
Notification regarding unquoted securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/154a515cf99b37a1eec3588f9a8b1a6f |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-09-16 08:19:57 |
Notification of cessation of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0fac892b5f492b3f7613477e10852e14 |
Appendix 3H (Notification of cessation of securities)
|
2024-09-24 08:23:53 |
Date of AGM and Closing Date for Director Nominations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/79df6d48abe1237960c75513c51406db |
Notice of Meeting - Other
|
2024-09-30 09:13:10 |
Proposed issue of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8a5b5b8ba876c83dcda553dfc7bef936 |
|
2024-10-01 17:04:01 |
Notification regarding unquoted securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8c52529a301567e2471e68a0393d5997 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-10-08 09:09:08 |
Alliance for Regenerative Medicine Meeting Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/57c68f19905f268139a930a862f2b676 |
|
2024-10-18 13:43:41 |
Letter to Shareholders, Notice of AGM & Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f54ba22bcc093e192a9887976a0a7e71 |
Notice of Annual General Meeting
|
2024-10-18 13:44:43 |
Annual Report to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d263a721b289e26419c41a22d0fa5459 |
Full Year Directors' Statement
Full Year Directors' Report
|
2024-10-25 13:10:08 |
Quarterly Activity Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3861b38a21796c797dc754cebcc03452 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2024-11-08 17:32:31 |
Application for quotation of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/062e8e3bc4a26bfa3f2125f2b89c01d4 |
Appendix 2A (Application for Quotation of Securities
|
2024-11-08 17:35:34 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/014b2e943362a18bffae1faeb367f53e |
|
2024-11-12 08:57:56 |
Updated Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/db515504bf45fb5fc4671b34f4a0c4b1 |
|
2024-11-19 08:24:56 |
AGM Presentations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7d95aef9befae2af852e5bfa0286958c |
Chairman's Address to Shareholders
|
2024-11-19 12:01:00 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f500e828af59a20b9187dadd1e4185a |
|
2024-11-26 15:24:23 |
Cynata Receives $1.88m R&D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a55ab9f5761119f0532747b68ecf22e7 |
Company Administration - Other
|
2024-12-04 08:43:41 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e8f29ebeab887682954a9597b348356b |
|
2024-12-05 10:40:02 |
Demonstrated Safety & Efficacy in DFU Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/41c6b7994ca11950a020decf57c53664 |
|
2024-12-06 09:37:22 |
Cynata secures commitments for $8.1m institutional placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c16c4f6cf920d54440c4e913f5a4e9f6 |
|
2024-12-06 09:37:24 |
Proposed issue of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fca08ba4070f58c861ba2a2de9401e4b |
|
2024-12-06 09:37:25 |
Proposed issue of securities - CYP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8714ef10b01bb79793d1917ffb43a832 |
|